Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary results

18 Jan 2011 07:00

RNS Number : 6228Z
Arden Partners plc
18 January 2011
 



Immediate release 18 January 2011

 

Arden Partners plc

("Arden" or the "Company")

 

Preliminary results for the year ended 31 October 2010

 

 

Arden Partners plc (AIM: ARDN), the institutional stockbroking company, today announces preliminary results for the year ended 31 October 2010.

 

Financial highlights

 

·; Revenue £13.0 million (2009: £13.1 million)

 

·; Underlying profit before tax* £1.3 million (2009: £2.2 million)

 

·; Underlying basic earnings per share** 2.4p (2009: 8.0p)

 

* Profit before tax as adjusted for the effect of share based payments and reorganisation costs

** Basic earnings per share as adjusted for the after-tax effect of share based payments and reorganisation costs

 

Operational highlights

 

·; Total funds raised for clients £183m (2009: £73m)

 

·; Fifteen transactions during the year, comprising ten M&A, four secondary fundraisings, and one IPO

 

·; Corporate Finance revenue increased by 57% to £6.9m (2009: £4.4m)

 

Commenting on the results and Arden's outlook, Lord Flight, Interim Chairman, said:

 

"At an operational level, the Board is overseeing changes designed to focus coverage and resource on core UK sectors and those with reach into India...the Board believes the Group is well placed to deliver profitability in the current financial year. Our closing balance sheet is strong with a healthy regulatory capital position."

 

Arden Partners plc 020 7614 5900

Jonathan Keeling - Chief Executive Officer

Trevor Norris - Group Finance Director

 

Altium 020 7484 4040

Phil Adams / Sam Fuller

 

Buchanan Communications 020 7466 5000

Mark Edwards / James Strong

 

 

 

Chairman's Statement

 

The year's results are satisfactory and have been delivered against a background of challenging conditions and subdued equity markets. Despite this, I am pleased to have seen the Group deliver an underlying profit and positive operating cash flows before changes in working capital. These results should also be read in the context of the trading update which the Board released on 10 September 2010 then advising that the Group was unlikely to meet market expectations. At that stage there was no clarity that certain transactions in the pipeline would be delivered by the year end so it was deemed prudent to issue the update. Subsequently two large transactions occurred by the year end as announced on 2 November 2010.

 

Arden operates in a highly competitive market place and to succeed a broking business needs to have either scale or specialist products. The Board has considered potential acquisitions and merger opportunities but none were considered suitable. In the latter months of 2010 Arden has sought to reorganise and position itself to compete in what could be continued difficult markets. To this end the Group has made changes at both Board and operating levels.

 

On 22 December 2010 we announced a number of Board changes with the appointment of two new independent Non Executive Directors with expertise in the Group's two main revenue generating areas, Mark Ansell and Peter Moon. At the same time the Group also announced the appointment of its Chief Operating Officer, Steve Wassell, as an Executive Director. This appointment was designed to assist our Chief Executive Officer, Jonathan Keeling, to continue to focus on our growing Indian franchise.

 

At an operational level, the Board is overseeing changes designed to focus coverage and resource on core UK sectors and those with reach into India. Following the departure of a number of staff earlier in the year, and with tight management of fixed overhead costs, the Board believes the Group is well placed to deliver profitability in the current financial year. Our closing balance sheet is strong with a healthy regulatory capital position.

 

On behalf of all of Arden's stakeholders I would like to thank both Sir David Rowe-Ham and Tony Bartlett following their retirement from the Board at the end of December 2010. Sir David has been Chairman since Arden's admission to AIM in July 2006 and Tony has carried out various roles, including that of CEO, having been involved with Arden almost since its inception in 2002.

 

Finally, I would like to thank all staff and clients for their commitment to the business.

 

Lord Flight

Interim Chairman

 

 

Chief Executive's Statement

 

Introduction

I am pleased to report that the Group has had a satisfactory year in a challenging market. The Group made an underlying profit of £1.3m before charging £1.8m for both share-based payments (IFRS 2) and one-off reorganisation costs giving rise to a loss before taxation of £0.5m (2009: profit £1.5m). The Group also generated cash from operations, before adjustment for movements in working capital, of £0.6m (2009: £2.3m).

 

Total revenues at £13.0m are on a par with the previous year (£13.1m) but based on a different mix with 53% derived from corporate finance fees and retainers (2009: 34%). In the last few weeks of the financial year the Group secured two large corporate placings which raised some £98m for clients. Revenues generated by our Equities Division were down by 29% to £6.1m from £8.6m. This statistic was the result of a number of factors including reduced trading volumes in the London markets, lower returns from Institutions and increased competition from other exchange venues.

 

During the year the Group carried out a reorganisation which involved a number of staff leaving giving rise to costs for the Group of £0.7m. We also revisited other overheads and some of these have also been rationalised. This leaves the Group with a lower fixed overhead going forward and a refocused strategy at both Group and operating levels which is designed to deliver higher revenue per head.

 

Financial Review

Revenue in the year ended 31 October 2010 was £13.0m compared to £13.1m in 2009. The underlying profit before tax was £1.3m compared to £2.2m. The loss before taxation, which is stated after charging share-based payments and reorganisation costs, was £0.5m and compares to a profit before taxation in 2009 of £1.5m. Cash generation was strong with balances at the year end of £9.0m (2009: £10.5m) together with long market making positions of £3.0m (2009: £2.5m). During the year the Company migrated settlement services from Pershing to BNP Paribas Securities Services and this necessitated a deposit of £0.6m to cover base collateral requirements. Cash balances at the year end represented some 283% of our regulatory capital requirement.

 

The underlying earnings per share (before charging share based payments and reorganisation costs) was 2.4p compared to 8.0p in 2009. The basic loss per share was 4.2p compared to earnings per share of 5.1p in 2009.

 

During the period between 5 November and 9 November 2010 the Company purchased 1,933,521 ordinary shares of 10p each at a price of 49p per share. All of these shares will be held in Treasury.

 

Equities Division

Our Equities Division revenue decreased by 29% to £6.1m from £8.6m. Whilst underlying commission levels fell by only 4%, income from share placings and market making returns were lower than anticipated.

 

Corporate Finance

During the year we completed fifteen corporate finance transactions (2009: twelve) including ten M&A mandates, four secondary fundraisings and one IPO. Including retainer income, total corporate finance revenues increased by some 57% to £6.9m from £4.4m.

 

Outlook

The current year has started satisfactorily and Arden has completed one fundraising to date. The Equities Division continues to see pressure on margins, as in the previous year, and the corporate finance pipeline, whilst satisfactory, remains market dependent. With tight cost control and a strong balance sheet a positive result for the full year is anticipated.

 

Finally, I would like to take this opportunity to thank our staff for their commitment through challenging conditions.

 

Jonathan Keeling

Chief Executive Officer

 

 

 

Consolidated Statement of Comprehensive Income

For the year ended 31 October 2010

 

 

2010

2009

 

Note

£'000

£'000

Revenue

2

13,046

13,059

Administrative expenses

(13,622)

(11,622)

(Loss)/profit from operations

(576)

1,437

Finance income

73

86

Finance costs

(9)

(1)

(Loss)/profit before taxation

(512)

1,522

Income tax expense

(519)

(276)

(Loss)/profit after taxation

(1,031)

1,246

Other comprehensive income:

Movement in fair value of available for sale investments

-

2

Other comprehensive income for the year

-

2

Total comprehensive (loss)/income for the year attributable to equity shareholders

(1,031)

1,248

 

 

(Loss)/earnings per share

Basic

4

(4.2)p

5.1p

Diluted

4

(4.2)p

4.8p

 

 

 

Consolidated Statement of Financial Position

At 31 October 2010

 

2010

2010

2009

2009

 

Note

£'000

£'000

£'000

£'000

Assets

Non-current assets

Property, plant and equipment

401

258

Deferred tax asset

280

618

Total non-current assets

681

876

Current assets

Trading investments

3,207

2,660

Trade and other receivables

6,210

15,660

Cash and cash equivalents

9,014

10,523

Total current assets

18,431

28,843

Total assets

19,112

29,719

Current liabilities

Trade and other payables

(6,895)

(17,182)

Corporation tax liability

(171)

(685)

Total current liabilities

(7,066)

(17,867)

Non-current liabilities

Deferred tax liability

(53)

(44)

Total non-current liabilities

(53)

(44)

Total liabilities

(7,119)

(17,911)

Net assets

11,993

11,808

 

Shareholders'equity

 

 

 

 

 

Called up share capital

2,544

 

2,494

Share premium account

2,926

 

2,736

Employee Benefit Trust Reserve

(648)

 

(648)

Retained earnings

7,171

 

7,226

Total equity

11,993

 

11,808

 

 

 

Consolidated Statement of Cash Flows

For the year ended 31 October 2010

 

 

2010

2009

 

£'000

£'000

Operating activities before taxation

Net (loss)/profit before tax

(512)

1,522

Adjustments for:

Fair value adjustments

(155)

(116)

Depreciation

236

256

Impairment of available for sale investments

-

20

Net interest receivable

(64)

(85)

Share based payments

1,079

702

Operating cash flow before changes in working capital

584

2,299

Decrease/(increase) in trade and other receivables

9,439

(12,525)

Increase in financial assets

(400)

(2,313)

(Decrease)/increase in trade and other payables

(10,266)

14,235

Purchases of available for sale investments

-

(27)

Cash generated from operations

(643)

1,669

Income taxes paid

(790)

(200)

Cash flows from operating activities

(1,433)

1,469

Investing activities

Purchases of property, plant and equipment

(379)

(191)

Interest received

63

98

Net cash from investing activities

(316)

(93)

Financing activities

Purchase of own shares

-

(448)

Issue of shares

240

114

Net cash from financing activities

240

(334)

(Decrease)/increase in cash and cash equivalents

(1,509)

1,042

Cash and cash equivalents at the beginning of the year

10,523

9,481

Cash and cash equivalents at the end of the year

9,014

10,523

 

 

 

Consolidated Statement of Changes in Equity

For the year ended 31 October 2010

 

Share

capital

Share

Premium

account

Employee

Benefit Trust

reserve

Retained

earnings

Total

£'000

£'000

£'000

£'000

£'000

Balance at 31 October 2009

2,494

2,736

(648)

7,226

11,808

Loss for year

-

-

-

(1,031)

(1,031)

Total comprehensive loss for the year

-

-

-

(1,031)

(1,031)

Tax taken to equity

-

-

-

(103)

(103)

Share based payments

-

-

-

1,079

1,079

Issue of shares

50

190

-

-

240

Balance at 31 October 2010

2,544

2,926

(648)

7,171

11,993

 

 

Consolidated Statement of Changes in Equity

For the year ended 31 October 2009

 

Share

capital

Share

premium

account

Employee

Benefit Trust

reserve

Available

for sale

reserve

Retained

earnings

Total

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 31 October 2008

2,470

2,646

(200)

(2)

5,204

10,118

Profit for year

-

-

-

-

1,246

1,246

Other comprehensive income for the year

-

-

-

2

-

2

Total comprehensive income for the year

-

-

-

2

1,246

1,248

Tax taken to equity

-

-

-

-

74

74

Share based payments

-

-

-

-

702

702

Issue of shares

24

90

-

-

-

114

Purchase of own shares

-

-

(448)

-

-

(448)

Balance at 31 October 2009

2,494

2,736

(648)

-

7,226

11,808

 

Notes

 

1. The Employee Benefit Trust reserve represents shares held in the parent company by the Arden Partners Employee Benefit Trust, which is consolidated in these financial statements.

2. The Available for sale reserve represents unrealised gains and losses on available for sale investments, being the difference between the acquisition cost and fair value at the balance sheet date. The reserve is shown net of related deferred tax.

 

NOTES

1) Basis of preparation

The financial information set out in this announcement has been prepared in accordance with the recognition and measurement principles of IFRS as endorsed for use in the European Union.

The financial information set out in this announcement does not constitute the group's statutory accounts for the year ended 31 October 2010 or year ended 31 October 2009 under the meaning of s434 Companies Act 2006, but is derived from the 2010 annual report and accounts.

Statutory accounts for the years ended 31 October 2010 and 31 October 2009 have been reported on by the Independent Auditors. 

The Independent Auditors' Report on the Annual Report and Financial Statements for the years ended 31 October 2010 and 31 October 2009 was unqualified, did not draw attention to any matters by way of emphasis, and did not contain a statement under 498(2) or 498(3) of the Companies Act 2006.

Statutory accounts for the year ended 31 October 2009 have been filed with the Registrar of Companies. The statutory accounts for the year ended 31 October 2010, prepared under IFRS, will be delivered to the Registrar in due course.

 

2) Revenue

 

Revenue is wholly attributable to the principal activity of the Group and arises solely within the United Kingdom.

 

 

 

2010

2009

 

 

£'000

£'000

Equities Division

 

6,113

8,613

Corporate Finance Division

 

6,933

4,446

Total revenue

 

13,046

13,059

 

Included within revenue of the Equities Division is an amount of £37,000 (2009: £157,000) relating to the fair value adjustment of derivatives held within trading investments that are fair valued through profit or loss.

 

The Directors are of the opinion that there are only two business segments and that business resources cannot be readily allocated to segments for the purposes of deriving either profit or net assets.

 

3) Employees

 

Staff costs (including Directors) of the Group consist of:

 

 

 

2010

2009

 

 

£'000

£'000

Wages and salaries

 

5,669

4,100

Incentive payments

 

365

944

Share based payments

 

1,079

702

Social security costs

 

571

582

Other pension costs

 

474

419

 

 

8,158

6,747

 

Staff costs include an amount of £693,000 (2009: £Nil) in respect of reorganisation payments. The average number of employees (including Directors) of the Group and Company during the year was 58 (2009: 55) of which 43 (2009: 41) are front-office and the remainder are administration.

 

4) Earnings per Share

In addition to the basic earnings per share, underlying earnings per share has been shown because the Directors consider that this gives a more meaningful indication of the underlying performance of the Group. Where applicable, all adjustments are stated after taking into consideration the appropriate tax treatment.

 

 

Year ended

31 October 2010

Year ended

31 October 2009

 

Pence per

Share

Numerator

£'000

Pence per

Share

Numerator

£'000

Basic (loss)/earnings per share

(4.2)

(1,031)

5.1

1,246

Add: IFRS2 share-based payments

4.4

1,079

2.9

702

Add: Reorganisation payments and aborted bid costs

2.2

532

-

-

Underlying basic earnings

2.4

580

8.0

1,948

 

Diluted (loss)/earnings per share *

(4.2)

(1,031)

4.8

1,246

Add: IFRS2 share-based payments

3.9

1,079

2.7

702

Add: Reorganisation payments and aborted bid costs

1.9

532

-

-

Underlying diluted earnings

1.6

580

7.5

1,948

 

 

Year ended 31 October 2010

Year ended 31 October 2009

 

 

Number

Number

 

Denominator

 

Weighted average number of shares in issue for Basic Earnings calculation

24,540,847

24,209,343

 

Weighted average dilution for outstanding share options

3,092,296

1,828,105

 

Weighted average number for diluted earnings calculation

27,633,143

26,037,448

 

 

 

Note *: As the Group made a loss for the year ended 31 October 2010, in accordance with IAS 33 no adjustment is made to the basic loss per share in deriving the diluted loss/earnings per share.

 

The weighted average dilution for outstanding share options was 3,092,296 (2009: 1,828,105). The 774,994 (2009: 573,243) shares held by the Arden Partners Employee Benefit Trust have been treated as cancelled and excluded from the denominator.

 

 

 

5) Annual Report and Accounts

Copies of the 2010 Report and Accounts will be posted to shareholders in due course. Copies will also be available from the Company's registered office and from the Company's website.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR GMGMMMNFGMZZ
Date   Source Headline
28th Apr 202210:15 amRNSOffer Update - Scheme of Arrangement - Effective
28th Apr 20227:30 amRNSSuspension - Arden Partners PLC
28th Apr 20227:00 amRNSNomad register change - Arden Partners Plc
27th Apr 20224:30 pmRNSOffer Update-Court Sanction, Scheme of Arrangement
27th Apr 20224:30 pmRNSOffer Update - Court Sanction of Scheme
21st Apr 20225:30 pmRNSInce Group
19th Apr 20222:00 pmRNSOffer Update – Extension of FCA approval
19th Apr 20222:00 pmRNSExtension of FCA Change of Control Approval
14th Apr 20227:00 amRNSOffer Update - Timetable for completion of Scheme
14th Apr 20227:00 amRNSOffer Update - Timetable for Completion of Scheme
12th Apr 202211:55 amRNSForm 8.5 (EPT/NON-RI)
11th Apr 20227:00 amRNSOffer update – Waiver of NOMAD condition
11th Apr 20227:00 amRNSOffer Update - Waiver of NOMAD Condition
8th Apr 20222:19 pmRNSPublication of Annual Report and Notice of AGM
7th Apr 20222:18 pmRNSHolding(s) in Company
7th Apr 20229:33 amRNSUpdate regarding the NOMAD condition
7th Apr 20227:00 amRNSUpdate Regarding the Nomad Condition
6th Apr 202211:41 amRNSForm 8.3 - Arden Partners plc
5th Apr 20227:00 amRNSAudited Results for the Year Ended 31 October 2021
18th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI) - AssetCo PLC
14th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202210:20 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20229:48 amRNSForm 8.3 - Ince Group PLC
7th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
3rd Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
9th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
4th Feb 20221:03 pmRNSForm 8.5 (EPT/NON-RI)
2nd Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
1st Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20221:00 pmRNSForm 8.5 (EPT/NON-RI)
26th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
21st Jan 20227:00 amRNSApproval of the FCA condition
21st Jan 20227:00 amRNSFCA Approval of the Change of Control
20th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20224:30 pmRNSResults of Arden court meeting & general meeting
19th Jan 20224:24 pmRNSResults of Court Meeting and General Meeting
18th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 20212:30 pmRNSPublication of Scheme Document
15th Dec 20217:00 amRNSExtension Of Irrevocable Undertakings
8th Dec 20218:00 amRNSExtension Of Irrevocable Undertakings
1st Dec 20212:03 pmRNSForm 8 (DD) - The Ince Group plc
30th Nov 202111:55 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.